ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts
-
Published:2023-01-06
Issue:
Volume:10
Page:
-
ISSN:2296-634X
-
Container-title:Frontiers in Cell and Developmental Biology
-
language:
-
Short-container-title:Front. Cell Dev. Biol.
Author:
Pecori Riccardo,Chillón Isabel,Lo Giudice Claudio,Arnold Annette,Wüst Sandra,Binder Marco,Marcia Marco,Picardi Ernesto,Papavasiliou Fotini Nina
Abstract
Despite hundreds of RNA modifications described to date, only RNA editing results in a change in the nucleotide sequence of RNA molecules compared to the genome. In mammals, two kinds of RNA editing have been described so far, adenosine to inosine (A-to-I) and cytidine to uridine (C-to-U) editing. Recent improvements in RNA sequencing technologies have led to the discovery of a continuously growing number of editing sites. These methods are powerful but not error-free, making routine validation of newly-described editing sites necessary. During one of these validations on DDX58 mRNA, along with A-to-I RNA editing sites, we encountered putative U-to-C editing. These U-to-C edits were present in several cell lines and appeared regulated in response to specific environmental stimuli. The same findings were also observed for the human long intergenic non-coding RNA p21 (hLincRNA-p21). A more in-depth analysis revealed that putative U-to-C edits result from A-to-I editing on overlapping antisense RNAs that are transcribed from the same loci. Such editing events, occurring on overlapping genes transcribed in opposite directions, have recently been demonstrated to be immunogenic and have been linked with autoimmune and immune-related diseases. Our findings, also confirmed by deep transcriptome data, demonstrate that such loci can be recognized simply through the presence of A-to-I and U-to-C mismatches within the same locus, reflective A-to-I editing both in the sense-oriented transcript and in the cis-natural antisense transcript (cis-NAT), implying that such clusters could be a mark of functionally relevant ADAR1 editing events.
Funder
European Research Council
Deutsche Forschungsgemeinschaft
Agence Nationale de la Recherche
Fondation ARC pour la Recherche sur le Cancer
Publisher
Frontiers Media SA
Subject
Cell Biology,Developmental Biology